|
| |
GPC BiotechGPC Biotech AG is a publicly traded biopharmaceutical company focused on discovering, developing and commercializing new anticancer drugs. GPC Biotech's lead product candidate satraplatin is currently under review by the U.S. FDA for hormone-refractory prostate cancer patients whose prior chemotherapy has failed. Satraplatin was in-licensed from Spectrum Pharmaceuticals, Inc.
GPC Biotech is also developing a monoclonal antibody with a novel mechanism-of-action against a variety of lymphoid tumors, currently in Phase 1 clinical development, and has ongoing drug development and discovery programs that leverage its expertise in kinase inhibitors.
GPC Biotech AG is headquartered in Martinsried/Munich (Germany), and has a wholly owned U.S. subsidiary headquartered in Princeton, New Jersey.
| Contact Details: |
| Fraunhoferstr. 20 |
| Martinsried/Munich |
| |
| 82152 |
| Germany |
| Tel: | +49 (0)89 8565-2693 |
| Fax: | 1 781 890 9005 |
| Email: | info@gpc-biotech.com |
| WWW: | www.gpc-biotech.com/
|
| |
Recent Publications by GPC Biotech: |  |
Cyclin-dependent Kinases Phosphorylate the Cytomegalovirus RNA Export Protein pUL69 and Modulate Its Nuclear Localization and Activity.
Replication of human cytomegalovirus (HCMV) is subject to regulation by... | 27th May, 2009
| Institute for Clinical and Molecular Virology, University of
| J Biol Chem. 2009 Mar 27;284(13):8605-13. Epub 2009 Jan 29.
DOI Direct Link |
Preclinical antitumor activity of the oral platinum analog satraplatin.
PURPOSE: Satraplatin is an orally available platinum analog. The purpose... | 20th September, 2007
| From GPC Biotech, Fraunhoferstrasse 20, 82152 Martinsried/Munich, Germany.
| Cancer Chemother Pharmacol. 2007 Sep;60(4):589-600. Epub 2007 May 31.
DOI Direct Link |
Second-generation kinase inhibitors.
An increasing number of kinase inhibitor candidates are entering clinical... | 26th January, 2007
| GPC Biotech AG, Max-Lebsche-Platz 32, D-81377 Munich, Germany.
| Expert Opin Ther Targets. 2005 Oct;9(5):975-93.
DOI Direct Link |
MASPIT: three-hybrid trap for quantitative proteome fingerprinting of small molecule-protein interactions in mammalian cells.
Organic small molecules generally act by perturbing the function of one or... | 9th December, 2006
| GPC Biotech Incorporated, Waltham, Massachusetts 02451, USA.
| Chem Biol. 2006 Jul;13(7):711-22.
DOI Direct Link |
A small-molecule-protein interaction system with split-ubiquitin as sensor.
The identification of receptors for small molecules is of great... | 10th November, 2006
| GPC Biotech AG, Fraunhoferstrasse 20, 82152 Martinsried, Germany.
| Chembiochem. 2006 Jun;7(6):936-42.
DOI Direct Link |
→View more GPC Biotech research publications. |
Press Releases on GPC Biotech:
|
 |
| New Report Just Published: World Prostate Cancer Therapeutics Market Report |
7th July, 2009 |
Reportlinker |
NEW YORK, July 7 /PRNewswire/ -- Reportlinker.com just added a new market research report to its catalogue.
World Prostate Cancer Therapeutics Market
http://www.reportlinker.com/p0119471/World
|
| 2009 Pharma ChemOutsourcing Show Attendance Up an Astounding 60% Despite Current Recession |
3rd June, 2009 |
Apaporis LLC |
LONG BRANCH, N.J., June 3 /PRNewswire/ -- The 2009 Pharma ChemOutsourcing Conference & Exhibition attendance is way up again in 2009 and is poised to shatter the attendance record set in 2008.
|
| Agennix Receives Fast Track Designation From FDA for Talactoferrin in Combination With Sunitinib for Renal Cell Carcinoma |
19th May, 2009 |
Agennix |
HOUSTON, May 19 /PRNewswire/ -- Agennix announced today that talactoferrin alfa (talactoferrin) has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the first
|
| Pharma ChemOutsourcing Unveils 100 Pharma & Biotech Speaker Faculty for 2009 Conference September 14-16 in Long Branch, NJ |
10th March, 2009 |
Apaporis, LLC |
LONG BRANCH, N.J., March 10 /PRNewswire/ -- The long-awaited speaking faculty for the September Pharma ChemOutsourcing Conference & Exhibition has been posted on the conference website reports
|
| Sopherion Therapeutics Announces Appointment of New Senior Executive Vice President for Clinical Affairs |
24th February, 2009 |
Sopherion Therapeutics, LLC |
PRINCETON, N.J., Feb. 24 /PRNewswire/ -- Sopherion Therapeutics, LLC, a biopharmaceutical company focused on the development and commercialization of anti-cancer therapies, has announced the
|
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 584 times since April 2007, the link to the organisation's website has been followed 77 times Recent Search Terms used to find this page: maspit GPC Biotech | GPC decision No. 60 for 2007. | split-ubiquitin 2009 | . Search for more companies in Martinsried/Munich Search for more companies in This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for GPC Biotech |
